“…Nonetheless, since administration of aerosolized corticosteroids to the preterm infant has limited effectiveness in preventing BPD and requires a delivery system which cannot guarantee selective delivery of inhaled steroids to the alveoli [38], their direct intratracheal administration using surfactant as a vehicle may be a suitable way to deliver topical steroids and thus avoid their side effects on cardiovascular function, glycemia, the immune system, and neurodevelopment, while maintaining their favorable effect on lung tissues. On the other hand, Nimmo et al [39] have previously demonstrated that natural surfactant is an effective vehicle for pulmonary delivery of corticosteroids. The possible absorption of beclomethasone administered through the intratracheal route has not been investigated so far, but data from studies on its intranasal use suggest that the propionate ester of this agent (which was used in our study) is highly lipophilic, and this favors its mucosal absorption and uptake across phospholipid cell membranes with negligible systemic absorption [40].…”